GaMF1.39
GaMF1.39 is an antimycobacterial compound, targeting the F-ATP synthase subunit γ. GaMF1.39 displays enhanced anti-tuberculosis activity in combination with ETC inhibitors[1].
Product Specifications
CAS Number
2568607-82-7
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gamf1-39.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC=C(C2=NC3=C(C=CC(NC4=NC(NCC)=CC(C)=N4)=C3)N2)C=C1
Molecular Formula
C20H19ClN6
Molecular Weight
378.86
References & Citations
[1]Ragunathan P, et al. GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876. Microbiol Spectr. 2023;11 (6) :e0228223.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
